Federal Awards

Adinoff, Bryon, NIH, Lidocaine as a Treatment for Cocaine Relapse and Craving, $195,768; Bai, Xiaoying, NIH, Role of Transcription Pausing in Hematopoietic Stem Cell Development, $354,487; Banerjee, Subhash, UT Arlington/NIH, Novel Engineered Particle Platform for Endothelium Regeneration, $37,800; Berglund, Eric, NIH, Regulation of Hepatic Substrate Flux by Leptin via POMC Neurons and Hepatocytes, $101,844; Cannon, Stephen, NIH, Molecular Physiology of Myotonia and Periodic Paralysis, $381,864; Carroll, Thomas, NIH, Delineating a Role for Non-Canonical Wnt Signaling in PKD, $345,825;

Casey, Brian, NIH, NICHD Maternal Fetal Medicine Units Network, $313,230; Casey, Brian, George Washington Univ/NIH, MEFU NICHD Network, $142,130; Chen, Benjamin, NIH, DNA-PKcs Phosphorylation on Hematopoietic Stem Cells Genome Maintenance, $329,925; Chen, David, NIH, Pathway Choice of DNA Double-Strand Break Repair, $329,925; Cowell, Lindsay, NIH, RepServer: Antigen Receptor Repertoire Analysis Pipelines via the WWW, $598,306; Diamond, Marc, NIH, Cell-Cell Transfer and Propagation of Tau Aggregates, $182,400; Eisch, Amelia, NASA, HZE Particle Exposure-Induced Improvement of Pattern Separation in Mature Mice: Alterations in Mission Relevant Behaviors and Neural Circuitry, $448,499;

Greenberg, David, NIH, Gene Silencing Therapeutics for Chronic Infections in Cystic Fibrosis, $367,923; Heyne, Roy, Children’s Hosp pf Phila/NIH, Structural Development of Human Fetal Brain, $12,873; Hibbs, Ryan, NIH, Structural Biology of the Alpha4beta2 Nicotinic Acetylcholine Receptor, $166,798; Hilgemann, Donald, NIH, Palmitoylation-Dependent Massive Endocytosis (pMEND), $391,537; Hill, Joseph, NIH, Training in Cardiovascular Research, $400,391; Hill, Joseph (Fellow M. Xie), NIH, Autophagy-Dependent Cardioprotection in Ischemia/Reperfusion Injury, $132,300;

Hofmann, Sandra, NIH, Role of DHHC Protein Palmitoyltransferases in Non-Small Cell Lung Cancer, $207,495; Hsia, Connie, NIH, Nanoparticle Drug Delivery in Post-Pneumonectomy Compensatory Lung Growth, $54,588; Hsieh, Jenny, NIH, Optogenetic Intervention of Pro-Epileptic Aberrant Neurogenesis, $215,640; Johnson, Jane, NIH, bHLH Transcription Factors in Neural Development, $329,427; Johnson, Mark, Yale Univ/NIH, Insulin Resistance Intervention after Stroke (IRIS) Trial, $812; Journeycake, Janna, UT HSC at Houston/CDC, American Thrombosis and Hemostasis, $21,756;

Karp, David, Penn State Hershey Med Ctr/NIH, Hydroxychloroquine Treatment for Prevention of Systemic Lupus Erythematosus, $65,426; Karp, David, Benaroya Rsrch Inst/NIH, CALIBRATE - Rituximab Plus Cyclophosphamide Followed by Belimumab Clinical Trial, $27,667; Knudsen, Erik, NIH, Role of the RB Tumor Suppressor in Liver Tumorigenesis, $398,137; Kowalske, Karen, UT Medical Branch/Dept of Defense, Early Exercise in the Burn Intensive Care Unit, $72,324; Le, Lu Quang, NIH, Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics, $329,925;

Levine, Beth, Washington Univ/NIH, Autophagy-Inducing Peptides and Target Identification for Treatment of Viruses, $1,288,836; Lin, Weichun, NIH, Patterning and Formation of Neuromuscular Junction, $347,813; Liu, Qinghua, NIH, Molecular Mechanisms of the RNAi/MicroRNA Pathways, $339,150; Liu, Xin, NIH, Molecular Mechanisms of Promoter-Terminator Gene Looping, $305,331; Lum, Lawrence, NIH, Chemical Disruption of Wnt-Mediated Signal Transduction, $464,007; Marciano, Denise, NIH, Role of Afadin Signaling in Nephron Tubulogenesis, $345,825;

Mason, Ralph, NIH, Optoacoustic Tomography System for Small Animals, $509,548; Michaely, Peter, NIH, Characterization of Role of ARH on LDLR Function, $20,272; Miller, David, Gynec Oncol Grp/NIH, Gynecologic Oncology Group Studies (Per Capita), $5,600; Moe, Orson, NIH, Klotho and FGF23 in Chronic Kidney Disease: Pathogenesis and Potential Therapy (MPI), $345,825; Paulk, Elizabeth, Cornell Univ/NIH, Latino vs. Non-Latino Disparities in Advance Care Planning & EOL Care, $61,641; Raskin, Philip, Case Western Reserve Univ/NIH, Residual Beta Cell Function in Patients with Long-Term Type 1 Diabetes, $52,259; Raskin, Philip, Benaroya Rsrch Inst/NIH, EXTEND - Preserving Beta-Cell Function with Tocilizumab in New Onset Type 1 Diabetes, $8,571;

Ready, Joseph, NIH, Synthesis and Evaluation of Biologically Active Natural Products, $294,701; Rethorst, Chad, NIH, Exercise Intervention to Prevent Interferon-Induced Depression in Hepatitis C Patients, $148,640; Rice, Luke, Natl Science Fdn, CAREER: Understanding Microtubule Dynamics Using Biochemically-Defined Tubulin Mutants to Integrate Structure, Biochemistry and Kinetics, $230,390; Rizo-Rey, Jose, NIH, Neurotransmitter Release Machinery: Structure and Function, $459,491; Rizo-Rey, Jose, NIH, Regulation of Neurotransmitter Release by C2-Domain Proteins, $447,875;

Robertson, Danielle, NIH, Interactive Effects of OSA and T2DM on Corneal and Ocular Surface Disease, $194,775; Rodan, Aylin, NIH, Using Drosophila to Understand WNK and SPAK/OSR1 Regulation of SLC12 Cotransporters, $145,331; Rogers, Zora, NIH, Baby HUG Follow-Up Study II, $171,817; Rothermel, Beverly (Fellow V. Parra), Univ of Maryland/NIH, Using iPSCs to Model Disruption of Mitochondrial Fission/Fusion in Down Syndrome, $7,000; Sadek, Hesham, NASA, Long-Term Effect of Space Radiation on Cardiomyocyte Turnover, $358,997; Schaffer, Joseph, RTI Intl/NIH, NICHD Pelvic Floor Disorders Network, $121;

Schiller, Joan, NIH, UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10, $700,000; Schiller, Joan, ECOG/NIH, ECOG Clinical Trials – Federal Payments, $9,775; Schmid, Sandra, NIH, Defining the Role of Dynamin in Endocytosis, $382,250; Sherry, Dean, NIH, PARACEST Agents for Molecular Imaging of Cancer by MRI, $267,977; Skapek, Stephen, NIH, Tgf Beta 2 Controls p19Arf During Eye Development, $389,550; Sun, Xiankai, SRI Intl/NIH, Multi-Layered Valency: A Novel Design of Peptidic Imaging Agents for avß6, $99,840; Thomas, Philip, NIH, Development of Membrane Protein Structure, $364,266;

Trivedi, Madhukar, NIH, Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care: EMBARC – Additional Advertising Supplement, $508,775; Trivedi, Madhukar, NIH, Clinical Trial Network: North Texas Node – Supplement for CTN-49 and CTN-53, $466,811; Trivedi, Madhukar, NIH, Clinical Trial Network: North Texas Node – Supplement for CTN-37, $153,522; Wan, Yihong, NIH, Connection of Mineral and Energy Metabolism by Nuclear Receptor PPAR-Gamma, $350,595; Wang, Jerry, NIH, Correction of B0 Inhomogeneity Induced by Orthodontic Appliances in MRI, $189,000; Weakley, David, Emory Univ/NIH, Infant Aphakia Treatment Study (IATS), $6,355;

Womack, Kyle, Baylor Rsrch Inst/Dept of Educ, North Texas Traumatic Brain Injury Model System, $57,680; Wyckoff, Myra, NIH, NICHD Cooperative Multicenter Neonatal Research Network, $313,230; Wyckoff, Myra, RTI Intl/NIH, NICHD Neonatal Research Network, $40,540; Xu, Che, NIH, Hybrid Scaffold Gel for the Treatment of Vocal Fold Lamina Propria Injury, $196,762; Xu, Jian, NIH, Characterizing the Role of BCL11A in Hematopoietic Development and Functions, $77,634; Xu, Wei, NIH, Neuronal Mechanisms for Fear Memory Generalization in PTSD and Anxiety Disorders, $249,000.

Nonfederal Awards

Bird, John, Food Allergy Rsrch & Educ, PITS, $41,169; Bowers, Daniel, Baylor Coll of Med/CPRIT, Proton Beam Radiation Therapy vs. Conventional Beam Radiation Therapy: Toxicities During and After Craniospinal Radiation Therapy in Children, $28,395; Brekken, Rolf, Univ of Houston/CPRIT, Tumor Cell Lytic Peptoids that Target Exposed Phosphatidylserine, $54,870; Brown, Edson, Stanley Medical Rsrch Inst, Ondansetron for Bipolar Disorder and Alcohol Use Disorders, $42,794; Choi, Changho, CPRIT, High Field MRS and CEST Imaging of Brain Tumors: Biomarkers of Therapeutic Response: P4, $267,146; Chopra, Rajiv, CPRIT, Recruitment of Rising Stars, $506,536; Costa, Daniel (Fellow A. Liu), Radiological Soc of North America, Principal Component Analysis on DWI and IVIM of the Prostate, $6,000; Cripps, Michael, East Fdn, East Trauma Research Scholarship, $39,996; Fox, Amanda, Fdn for Anesthesia Educ and Rsrch, FAER Medical Student Anesthesia Research Fellowship 2015 Summer Program, $4,200;

Frohman, Elliot, UT Dallas/NMMS, Auditory Processing in MS, $33,000; Galindo, Rene, American Cancer Soc, New Pathways Underlying Rhabdomyosarcoma Pathogenesis – Supplement, $50,000; Goodman, Joel, Texas Workforce Commission, STEEL: Student Training & Education Enhancement through Laboratories, $37,815; Horton, Jay, MIT Center for Cancer Rsrch/Skolkovo Inst, Program 2: The Genetic Basis of Disease, $323,500; Jaqaman, Khuloud, CPRIT, Recruitment of First-Time, Tenure-Track Faculty Members, $354,394; Jiang, Qiu-Xing, Cystic Fibrosis Fdn, A chemical Strategy for Studying CFTR Structure in Membrane, $108,000; Kraus, William (Fellow S. Gadad), Susan G. Komen for the Cure, Role of PARP-1 in Regulating Gene Expression in Breast Cancer Cells, $60,000; Malloy, Craig, CPRIT, Biomarkers and Metabolic Pathways in Gliomas: P2, $215,562; Mattrey, Robert, CPRIT, Developing and Translating Ultrasound and Nanotechnology to Enhance Cancer Imaging – Recruitment for Mattrey, $1,200,000;

Merritt, Matthew, CPRIT, Novel MRI and MRS Methods for Imaging Cancer Metabolism; P3, $214,956; Monteggia, Lisa, NARSAD, eEF2 kinase function in rapid antidepressant action, $100,000; Sherry, Dean, CPRIT, Novel MRI and MRS Methods for Imaging Cancer Metabolism: Admin, $31,367; Taurog, Joel, Spondylitis Assoc of America, ERAP1 in HLA-B27 Transgenic Rats, $100,000; Wakeland, Edward, Baylor Rsrch Inst/Critical Path Inst, Hollow Fiber System for ATuberculosis, $314,705; Westover, Kenneth, CPRIT, Recruitment of First-Time, Tenure-Track Faculty Members, $366,749; White, Michael, CPRIT, Cancer Intervention and Prevention Discoveries Program Years 4-5, $958,019; Word, Ann, March of Dimes Fdn, Fetal Fibronectin, Target of Therapy for Premature Rupture of Fetal Membranes, $85,373; Word, Ann (Fellow H. Annavarapu), March of Dimes Fdn, MOD Cervical Ripening, $125,000.

Industry Sponsored Awards

(Dollar amounts not available)

Anderson, Larry, Phase 2 Study of Single-Agent Filanesib (arrry-520) in Pts with Advanced Multiple Myeloma, Icon Clin Rsrch; Aquino, Victor, Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies, Natl Marrow Donor Prgm; Aquino, Victor, Phase 1/2 Study of CspaCIDe T Cells from HA-Partially Matched Family Donor after Negative Selection of TCR aB+T Cells in Ped pts Affected by Hematological Disorders, Bellicum Pharma; Beg, Muhammad, Phase 2 Trial of Nabpaclitaxel and Gemcitabine for Advanced or Metastatic Cholangiocarcinoma, Alpha Oncology; Bezprozvanny, Ilya, Evaluation of SK Modulators in SCA2 Mice, Ataxion Inc; Collins, Robert, Prospective Evaluation of Ruxolitinib Efficacy for CNL/a, Oregon Health & Science Univ; Courtney, Kevin, Phase 1 Dose Escalation Trial of PT2385, A HIF-2a Antagonist, in Pts with Advanced Clear Cell Renal Cell Carcinoma, Sarah Cannon Rsrch Inst;

Jessen, Michael, Novel Lung Trial Extension and REVIVE PAS Study: Normoth, Xvivo Perfusion Inc; Lee, William, Phase 3 Trial of Combination Regiment of MK-5172/MK-8742 in Treatment-Naive Sbjs with Chronic HCV GT1, GT5 and GT6 Infection, Merck Sharp & Dohme; Li, Xiaohong, Cancer Susceptibility/Resistance Screening, Daiichi Sanko; Mao, Weihua, Markerless Evaluations of Lung Tumor Motion Thru-Out RT, Elekta Limited; Phillips, Margaret, Development of Nucleotide Bio-marker Assay, Medicines For Malaria Venture; Rodriguez-Baez, Norberto, Phase 2 Study of Sofosbuvir + Ribavirin in Adoles & Children with Genotype 2 or 3 Chronic HCV Infection, Gilead Sciences; Scherer, Philipp, The POD-ATTAC Mouse, a Model for Podocyte Regeneration, Takeda Pharma Intl;

Sirsi, Deepa, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study of Clobazam as Adjunctive Therapy in Pediatric Pts 1-16 yrs with Dravet Syndrome, Quintiles; Sirsi, Deepa, Open Label, Long Term, Flexible Dose Study of Clobazam as Adjunctive Therapy in Pediatric Pts 1-16 yrs with Dravet Syndrome, Quintiles; Szmuk, Peter, Evaluation of Respiratory Acoustic Monitor in Children, Masimo Corp; Szmuk, Peter, Phase 4 Study of Phenylephrine and Blood Pressure Following IV Administration of Phenylephrine Hydrochloride Injection in Ped Sbjs (12-16 yrs) Undergoing General and Neuroaxial Anesthesia, PRA Health Sci; Wang, Jing, Advanced Applications of 4-D Cone-Beam Computed Tomography, Elektra Limited; Wang, Serena, Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children through 3 Yrs, Omeros Corp; Wilkie, Thomas, To Test if Diazonamide A will Reduce Pancreatic Cancer, Diazon Pharma.